Population Pharmacokinetic/Pharmacodynamic Analyses as the Basis for Dosing of Therapeutic Monoclonal Antibodies

被引：4
|
作者：
Meibohm, Bernd [1 ]
机构：
[1] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA
来源：
CLINICAL PHARMACOKINETICS | 2011年 / 50卷 / 12期
关键词：
MODEL;
D O I：
10.2165/11597950-000000000-00000
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：823 / 824
页数：2
相关论文
共 50 条
  • [21] Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
    Dirks, Nathanael L.
    Meibohm, Bernd
    CLINICAL PHARMACOKINETICS, 2010, 49 (10) : 633 - 659
  • [22] Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models
    Rosner, GL
    Muller, P
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1997, 25 (02): : 209 - 233
  • [23] Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint
    Duffull, Stephen B.
    Wright, Daniel F. B.
    Winter, Helen R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (06) : 807 - 814
  • [24] Bayesian Population Pharmacokinetic and Pharmacodynamic Analyses Using Mixture Models
    Gary L. Rosner
    Peter Müller
    Journal of Pharmacokinetics and Biopharmaceutics, 1997, 25 : 209 - 233
  • [25] Population pharmacokinetic analyses for belzutifan to inform dosing considerations and labeling
    Marathe, Dhananjay D.
    Jauslin, Petra M.
    Kleijn, Huub Jan
    Silva, Carolinade de Miranda
    Chain, Anne
    Bateman, Thomas
    Shaw, Peter M.
    Abraham, Anson K.
    Kauh, Eunkyung A.
    Liu, Yanfang
    Perini, Rodolfo F.
    de Alwis, Dinesh P.
    Jain, Lokesh
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (10): : 1499 - 1510
  • [26] POPULATION PHARMACOKINETIC AND EXPOSURERESPONSE ANALYSES SUPPORTING INDIVIDUALIZED DOSING OF OXYBATE
    Zhou, Honghui
    Wu, Liviawati
    Chen, Cuiping
    SLEEP, 2024, 47
  • [27] Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
    Anne S. Strik
    Yow-Ming C. Wang
    Laura E. Ruff
    William Yashar
    Bradley T. Messmer
    Diane R. Mould
    The AAPS Journal, 20
  • [28] PHARMACOKINETIC BASIS OF PHARMACODYNAMIC PREDICTIONS
    YOUNG, JF
    ACTA PHARMACEUTICA JUGOSLAVICA, 1984, 34 (01): : 1 - 10
  • [29] Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study
    Liang, Hao
    Deng, Zhenling
    Niu, Shu
    Kong, Weijie
    Liu, Yang
    Wang, Song
    Li, Haiyan
    Wang, Yue
    Zheng, Danxia
    Liu, Dongyang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [30] Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 1, monoclonal antibodies, antibody-drug conjugates and bispecific T-cell engagers
    Paci, Angelo
    Desnoyer, Aude
    Delahousse, Julia
    Blondel, Louis
    Maritaz, Christophe
    Chaput, Nathalie
    Mir, Olivier
    Broutin, Sophie
    EUROPEAN JOURNAL OF CANCER, 2020, 128 : 107 - 118
12345